Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Probart who wrote (81677)	3/12/2001 11:34:28 AM
From: Jim Bishop	Respond to of 150070

NUTX GNC, Rite Aid and Drugstore.com Enter Agreement With Nutraceutix Inc. for Calcium D-Glucarate REDMOND, Wash., Mar 12, 2001 (BW HealthWire) -- Nutraceutix Inc. (OTC BB: NUTX), a leading provider of proven technologies and products for the dietary supplement, over-the-counter (OTC) and prescription drug markets, finalized a licensing agreement with General Nutrition Centers Inc. (NASDAQ: GNCI) of Pittsburgh to market patented Calcium D-Glucarate through its own stores, and through Rite Aid Corp. (NYSE: RAD)(PSE: RAD) of Camp Hill, Pa., and Drugstore.com of Bellevue, Wash., on March 9, 2001. GNC has recognized Nutraceutix' exclusive license for patented Calcium D-Glucarate. Under the agreement, Nutraceutix will sub-license patented Calcium D-Glucarate to be incorporated into future dietary supplements containing D-Glucarate for pharmacist-recommended vitamins and dietary supplements, which are marketed jointly by GNC, Rite Aid, and Drugstore.com. Nutraceutix Inc. has acquired the exclusive sub-licensing rights from Biochemix Inc., based in Austin, Texas, to distribute Calcium D-Glucarate and to promote its applications for supporting breast, lung, liver, colon and prostate health in the nutritional supplement market. Calcium D-Glucarate is the patented form of glucaric acid, which is found naturally in the body, and which supports glucuronidation, a process in which the body detoxifies environmental carcinogens and other potentially harmful toxins. Calcium D-Glucarate has no known side effects. While glucaric acid is found primarily in fruits, such as apples and grapefruits, and in cruciferous vegetables, such as broccoli and cabbage, research indicates that increased levels of Calcium D-Glucarate achieved through supplementation are effective in assisting the body in detoxification. Researchers at AMC Cancer Research Center recently announced mounting research suggests the beneficial effects of Calcium D-Glucarate towards detoxification. Numerous animal studies conducted at AMC Cancer Research Center and other top research institutions demonstrate that increased levels of Calcium D-Glucarate through supplementation demonstrate greater health benefits. The research findings of Calcium D-Glucarate have been published in numerous peer-reviewed research journals. Nutraceutix Inc. possesses proven technologies and products for the nutraceutical industry. In addition to patented ingredients like Calcium D-Glucarate, Nutraceutix provides patented and proprietary technologies like CDT(TM) Controlled Delivery Technology, MDT(TM) Molecular Dispersion Technology, SET(TM) Self Emulsifying Technology and LiveBac(R) Probiotics. Nutraceutix technologies provide distinctive supplements with tangible benefits for the consumer and competitive commercial advantages. For more information on Nutraceutix, please call Marcia Rauser at 800/548-3222, or visit www.nutraceutix.com. Except for any historical information, the matters discussed in this press release contain forward-looking statements, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statement. CONTACT: ignite marketing group Margaret Anderson, 480/785-5252 Margaret@ignitemg.com www.nutraceutix.com URL: businesswire.com Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. Copyright (C) 2001 Business Wire. All rights reserved. -0- KEYWORD: PENNSYLVANIA TEXAS WASHINGTON INDUSTRY KEYWORD: FOODS/BEVERAGES MEDICAL PHARMACEUTICAL MARKETING AGREEMENTS * end of story *